This Article Full Text Full Text (PDF) Other Versions of this Article: CVI.00071-07v1 14/12/1587    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Connolly, P. A. Articles by Wheat, L. J. Search for Related Content PubMed PubMed Citation Articles by Connolly, P. A. Articles by Wheat, L. J.

Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay

MiraVista Diagnostics and Mirabella Technologies, Indianapolis, Indiana

Received 7 February 2007/ Returned for modification 24 May 2007/ Accepted 14 September 2007

The second-generation Histoplasma antigen immunoassay is semiquantitative, expressing results as a comparison to a negative control, which requires repeat testing of the prior specimen with the current specimen to accurately determine a change in antigen. Reporting results in this manner often is confusing to the ordering physician and laboratory. Development of a quantitative assay could improve accuracy, reduce interassay variability, and eliminate the need to test the prior sample with the current sample in the same assay. Calibrators with known concentrations of Histoplasma antigen were used to quantitate antigen in specimens from patients with histoplasmosis and from controls. Samples from cases of disseminated histoplasmosis or other mycoses and controls were tested to evaluate the performance characteristics of the quantitative assay. Paired specimens were evaluated to determine if quantitation eliminated the need to test the current and prior specimens in the same assay to assess a change in antigen. The sensitivity in samples from patients with AIDS and disseminated histoplasmosis was 100% in urine and 92.3% in serum. Cross-reactions occurred in 70% of other endemic mycoses, but not in aspergillosis. Specificity was 99% in controls with community-acquired pneumonia, medical conditions in which histoplasmosis was excluded, or healthy subjects. A change in antigen level categorized as an increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in nanograms/milliliter determined from testing current and prior specimens in different assays. Sensitivity, specificity, and interassay precision are excellent in the new third-generation quantitative Histoplasma antigen immunoassay.

Published ahead of print on 3 October 2007.

This article has been cited by other articles:

• Gutierrez, M. E., Canton, A., Connolly, P., Zarnowski, R., Wheat, L. J. (2008). Detection of Histoplasma capsulatum Antigen in Panamanian Patients with Disseminated Histoplasmosis and AIDS. CVI 15: 681-683 [Abstract] [Full Text]  
• Egan, L., Connolly, P. A., Fuller, D., Davis, T. E., Witt, J. III, Knox, K. S., Hage, C. A., Wheat, L. J. (2008). Detection of Histoplasma capsulatum Antigenuria by Ultrafiltration of Samples with False-Negative Results. CVI 15: 726-728 [Abstract] [Full Text]  
• Zhuang, D., Hage, C., De Jesus, M., Hackett, E., Durkin, M., Davis, T. E., Casadevall, A., Wheat, L. J. (2008). Cryptococcal Glucoxylomannan Does Not Exhibit Cross-Reactivity in the MVista Histoplasma Antigen Enzyme Immunoassay. CVI 15: 392-393 [Abstract] [Full Text]